Article metrics

Download PDFPDF
Extended report
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

 

Online download statistics by month:

Online download statistics by month: June 2016 to November 2021

AbstractFullPdf
Jun 20169625395
Jul 20163201934
Aug 20161211615
Sep 20161182324
Oct 20161451917
Nov 2016921716
Dec 2016114634149
Jan 201763019276
Feb 20172628496
Mar 20171624234
Apr 20171153416
May 20171176334
Jun 20171184123
Jul 20172034317
Aug 20173103927
Sep 20172482025
Oct 20172711920
Nov 20171882221
Dec 20173413728
Jan 20183894837
Feb 20182623227
Mar 20183463715
Apr 20182153415
May 2018298176
Jun 201818697
Jul 20182292416
Aug 20182392111
Sep 20181622017
Oct 20182052111
Nov 20182193015
Dec 20182211211
Jan 20191702118
Feb 20192091412
Mar 20192111710
Apr 201922584
May 20192691715
Jun 20192201813
Jul 201914272
Aug 2019185148
Sep 2019170198
Oct 20191851511
Nov 20192051410
Dec 2019164108
Jan 20201621410
Feb 20201761310
Mar 2020174117
Apr 2020250209
May 2020217129
Jun 2020206136
Jul 2020188188
Aug 2020175135
Sep 2020184136
Oct 2020129198
Nov 2020135134
Dec 2020162148
Jan 20212191510
Feb 202122977
Mar 20212961614
Apr 2021145158
May 202185107
Jun 202116146
Jul 2021444
Aug 2021984
Sep 202120148
Oct 202126566
Nov 202113531
Total1477614081439